KVK-Tech Signs Agreement of Sale to Acquire Lockheed-Martin Facility in Newtown, PA

Newtown, PA, March 2, 2015 – KVK-Tech is proud to announce that it has entered into an Agreement of Sale for the Purchase of Lockheed-Martin's Newtown, PA facility.
Under the terms of the Agreement, KVK will acquire the 460,000 sq. ft. facility in June, 2015. Lockheed Martin will continue to occupy the property under an agreement until the end of the year to facilitate its wind-down of operations. KVK will take possession and begin its fit-out in January, 2016.
Anthony Tabasso, KVK Tech's President and CEO, said "We are excited to add the Lockheed Facility to provide for the next stage of KVK's growth. In doing so, KVK is renewing its commitment to the Newtown business community. We expect to create quality jobs here over the next several years as we continue to manufacture high-quality pharmaceuticals exclusively in the USA. This acquisition will strengthen our organization and help us ensure that we continue to deliver world class products to our customers at a competitive price, and with unmatched reliability."
KVK-Tech is a leading American developer, manufacturer, and marketer of specialty pharmaceuticals located in Newtown, PA. http://www.kvktech.com/

Contact Information:
KVK-Tech
Anthony Tabasso President and CEO
[email protected]

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.